BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $864,638 | -18.8% | 17,217 | +2.2% | 0.01% | -22.2% |
Q2 2023 | $1,064,794 | +36.5% | 16,848 | -2.8% | 0.01% | +28.6% |
Q1 2023 | $779,947 | +5.6% | 17,336 | +2.9% | 0.01% | 0.0% |
Q4 2022 | $738,242 | -30.8% | 16,851 | +4.1% | 0.01% | -36.4% |
Q3 2022 | $1,067,000 | +31.7% | 16,188 | +0.9% | 0.01% | +37.5% |
Q2 2022 | $810,000 | -16.1% | 16,044 | +6.2% | 0.01% | 0.0% |
Q1 2022 | $965,000 | -39.8% | 15,110 | +0.9% | 0.01% | -33.3% |
Q4 2021 | $1,604,000 | +3.4% | 14,977 | -0.8% | 0.01% | -7.7% |
Q3 2021 | $1,552,000 | +17.9% | 15,097 | +0.9% | 0.01% | +18.2% |
Q2 2021 | $1,316,000 | -12.2% | 14,967 | -2.9% | 0.01% | -15.4% |
Q1 2021 | $1,499,000 | -12.2% | 15,412 | +1.2% | 0.01% | -13.3% |
Q4 2020 | $1,708,000 | +18.6% | 15,227 | -2.0% | 0.02% | +7.1% |
Q3 2020 | $1,440,000 | +59.3% | 15,534 | +34.1% | 0.01% | +7.7% |
Q2 2020 | $904,000 | +40.8% | 11,585 | +5.6% | 0.01% | +18.2% |
Q1 2020 | $642,000 | – | 10,973 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |